Article
Cardiovascular Effects of Tyrosine Kinase Inhibitors in Patients With Advanced Renal Cell Carcinoma at the VA San Diego Healthcare System
- Author:
- Angela Yuen, PharmD, BCOP
- Bailey Crandall, PharmD, BCPS, BCOP
Patients who have or are at high risk for developing cardiovascular disease and who are taking tyrosine kinase inhibitors for renal cell carcinoma...